Frazier Life Sciences Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Frazier Life Sciences Management’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,987,207	Closed	-$143M	–	52
2022 Q4	$143M	Buy	3,987,207 +1,015,933	+34%	+$25.4M	8.91%	2
2022 Q3	$44.7M	Hold	2,971,274	–	–	3.44%	9
2022 Q2	$39.8M	Hold	2,971,274	–	–	3.75%	9
2022 Q1	$57.3M	Buy	+2,971,274	New	+$61.6M	4.88%	6

Frazier Life Sciences Management's IMGO Position: Q1 2023 in Review

Frazier Life Sciences Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 3,987,207 shares — an estimated $143M sold.

Frazier Life Sciences Management first reported a position in IMGO in Q1 2022 and held it in 4 quarters. The position peaked at $143M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Frazier Life Sciences Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Frazier Life Sciences Management sold 3,987,207 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $143M.
Frazier Life Sciences Management first reported a position in Imago BioSciences, Inc. Common stock in Q1 2022 and held it in 4 quarters.
Frazier Life Sciences Management's Imago BioSciences, Inc. Common stock position peaked at $143M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Frazier Life Sciences Management's 13F filing for Q1 2023, filed 15 May 2023.